Vimarsana
Biggest News Aggregation in the World

Statement Regarding Forward Looking News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Statement Regarding Forward Looking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Statement Regarding Forward Looking Today - Breaking & Trending Today

Parkland Corporation Announces Second Quarter 2024 Dividend - Vimarsana News

Parkland Corporation Announces Second Quarter 2024 Dividend

CALGARY, AB, June 12, 2024 /CNW/ - Parkland Corporation announces that a dividend of $0.35 per share will be paid on July 15, 2024 to shareholders of record on June 21, 2024. The dividend will be an...

Gold Reserve Announces Submission of Credit Bid for CITGO Petroleum Corp. Parent Company, PDV Holdings, Inc. - Vimarsana News

Gold Reserve Announces Submission of Credit Bid for CITGO Petroleum Corp. Parent Company, PDV Holdings, Inc.

Gold Reserve Inc. is pleased to announce the submission of a credit bid for the common shares of PDV Holdings, Inc. , the indirect parent company of CITGO Petroleum Corp. . The Bid has been...

Sanofi: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3 - Vimarsana News

Sanofi: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3 Sarclisa, in combination

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD - Vimarsana News

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD

Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD - Vimarsana News

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD

Dupixent recommended for EU approval by the CHMP to treat patients with COPD Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3...